Nomura Asset Management Co. Ltd. Sells 1,680 Shares of CME Group Inc (CME)
Nomura Asset Management Co. Ltd. lowered its stake in CME Group Inc (NASDAQ:CME) by 2.0% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 81,397 shares of the financial services provider’s stock after selling 1,680 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in CME Group were worth $11,044,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. grew its stake in shares of CME Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 22,795,894 shares of the financial services provider’s stock worth $2,854,958,000 after buying an additional 563,460 shares during the last quarter. Capital International Investors boosted its stake in CME Group by 3.3% during the 2nd quarter. Capital International Investors now owns 11,209,987 shares of the financial services provider’s stock valued at $1,403,939,000 after purchasing an additional 359,845 shares during the last quarter. Janus Henderson Group PLC boosted its stake in CME Group by 13,530.7% during the 2nd quarter. Janus Henderson Group PLC now owns 6,150,016 shares of the financial services provider’s stock valued at $770,227,000 after purchasing an additional 6,104,897 shares during the last quarter. Wells Fargo & Company MN boosted its stake in CME Group by 25.5% during the 2nd quarter. Wells Fargo & Company MN now owns 4,379,568 shares of the financial services provider’s stock valued at $548,496,000 after purchasing an additional 889,217 shares during the last quarter. Finally, Thornburg Investment Management Inc. boosted its stake in CME Group by 5.4% during the 3rd quarter. Thornburg Investment Management Inc. now owns 3,902,886 shares of the financial services provider’s stock valued at $529,544,000 after purchasing an additional 200,483 shares during the last quarter. Institutional investors own 83.17% of the company’s stock.
In related news, Director Jeffrey M. Bernacchi sold 1,501 shares of the firm’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $149.75, for a total value of $224,774.75. Following the transaction, the director now directly owns 60,194 shares of the company’s stock, valued at approximately $9,014,051.50. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Sunil Cutinho sold 2,600 shares of the firm’s stock in a transaction on Friday, November 17th. The stock was sold at an average price of $139.57, for a total value of $362,882.00. Following the completion of the transaction, the insider now directly owns 22,301 shares in the company, valued at $3,112,550.57. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 34,921 shares of company stock worth $5,016,248. Company insiders own 0.57% of the company’s stock.
Several analysts have commented on the company. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Citigroup increased their target price on CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, October 19th. Barclays assumed coverage on CME Group in a research note on Friday, September 8th. They set an “overweight” rating and a $139.00 target price on the stock. Wells Fargo & Company increased their target price on CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research note on Wednesday, October 4th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and set a $133.00 target price on shares of CME Group in a research note on Thursday, September 21st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $141.75.
CME Group Inc (CME) opened at $152.11 on Wednesday. The stock has a market capitalization of $51,135.15, a price-to-earnings ratio of 31.55, a PEG ratio of 3.10 and a beta of 0.73. CME Group Inc has a 52 week low of $113.27 and a 52 week high of $155.29. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11.
CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.16 by $0.03. The firm had revenue of $890.80 million for the quarter, compared to the consensus estimate of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the business posted $1.05 EPS. research analysts predict that CME Group Inc will post 4.78 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Friday, December 8th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Thursday, December 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.74%. CME Group’s dividend payout ratio (DPR) is currently 59.86%.
COPYRIGHT VIOLATION WARNING: This piece was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://www.watchlistnews.com/nomura-asset-management-co-ltd-sells-1680-shares-of-cme-group-inc-cme/1746640.html.
CME Group Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.